Proton pump inhibitors (PPIs) Always review the label warnings carefully and follow the directions on the package
Any change in vision, severe abdominal pain, dehydration symptoms, or possible allergic reaction should be addressed promptly
12 Commonly, patients may experience gastrointestinal disturbances such as nausea, vomiting, diarrhea, and constipation
The pill, which contains an ingredient that helps deliver the fragile peptide to the body, is an alterative to an injectable version of the weight-loss drug, Wegovy, already on the market
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus and chronic weight management
But the pharmacological meaning is completely different